|
1
|
Seiferlein E, Haderlein T, Schuster M,
Gräßel E and Bohr C: Correlation between coping strategies and
subjective assessment of the voice-related quality of life of
patients after resection of T1 and T2 laryngeal tumours. Eur Arch
Otorhinolaryngol. 269:2091–2096. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Marur S and Forastiere AA: Head and neck
squamous cell carcinoma: Update on epidemiology, diagnosis, and
treatment. Mayo Clin Proc. 91:pp. 386–396. 2016; View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Olsen KD: Reexamining the treatment of
advanced laryngeal cancer. Head Neck. 32:1–7. 2010.PubMed/NCBI
|
|
4
|
Moser SE: Laryngeal problems. Prim Care.
41:99–107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Naldini L: Gene therapy returns to centre
stage. Nature. 526:351–360. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Arce-Sillas A, Álvarez-Luquín DD,
Tamaya-Domínguez B, Gomez-Fuentes S, Trejo-García A, Melo-Salas M,
Cárdenas G, Rodríguez-Ramírez J and Adalid-Peralta L: Regulatory T
cells: Molecular actions on effector cells in immune regulation. J
Immunol Res. 2016:17208272016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takeuchi Y and Nishikawa H: Roles of
regulatory T cells in cancer immunity. Int Immunol. 28:401–409.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Franco A, Almanza G, Burns JC, Wheeler M
and Zanetti M: Endoplasmic reticulum stress drives a regulatory
phenotype in human T-cell clones. Cell Immunol. 266:1–6. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chaudhry A, Samstein RM, Treuting P, Liang
Y, Pils MC, Heinrich JM, Jack RS, Wunderlich FT, Brüning JC, Müller
W and Rudensky AY: Interleukin-10 signaling in regulatory T cells
is required for suppression of Th17 cell-mediated inflammation.
Immunity. 34:566–578. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen N, Fang W, Zhan J, Hong S, Tang Y,
Kang S, Zhang Y, He X, Zhou T, Qin T, et al: Upregulation of PD-L1
by EGFR activation mediates the immune escape in EGFR-driven NSCLC:
Implication for optional immune targeted therapy for NSCLC patients
with EGFR mutation. J Thorac Oncol. 10:910–923. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Budczies J, Bockmayr M, Denkert C,
Klauschen F, Gröschel S, Darb-Esfahani S, Pfarr N, Leichsenring J,
Onozato ML, Lennerz JK, et al: Pan-cancer analysis of copy number
changes in programmed death-ligand 1 (PD-L1, CD274)-associations
with gene expression, mutational load, and survival. Genes
Chromosomes Cancer. 55:626–639. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qian Y, Deng J, Geng L, Xie H, Jiang G,
Zhou L, Wang Y, Yin S, Feng X, Liu J, et al: TLR4 signaling induces
B7-H1 expression through MAPK pathways in bladder cancer cells.
Cancer Invest. 26:816–821. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Winograd R, Byrne KT, Evans RA, Odorizzi
PM, Meyer AR, Bajor DL, Clendenin C, Stanger BZ, Furth EE, Wherry
EJ and Vonderheide RH: Induction of T-cell immunity overcomes
complete resistance to PD-1 and CTLA-4 blockade and improves
survival in pancreatic carcinoma. Cancer Immunol Res. 3:399–411.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liang X, Liu Y, Mei S, Zhang M, Xin J,
Zhang Y and Yang R: MicroRNA-22 impairs anti-tumor ability of
dendritic cells by targeting p38. PLoS One. 10:e01215102015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Remmele W and Stegner HE: Recommendation
for uniform definition of an immunoreactive score (IRS) for
immunohistochemical estrogen receptor detection (ER-ICA) in breast
cancer tissue. Pathologe. 8:138–140. 1987.(In German). PubMed/NCBI
|
|
17
|
Abd El Hafeez S, Torino C, D'Arrigo G,
Bolignano D, Provenzano F, Mattace-Raso F, Zoccali C and Tripepi G:
An overview on standard statistical methods for assessing
exposure-outcome link in survival analysis (Part II): The
Kaplan-Meier analysis and the Cox regression method. Aging Clin Exp
Res. 24:203–206. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang YM, Ghali J, Zhang GY, Hu M, Wang Y,
Sawyer A, Zhou JJ, Hapudeniya DA, Wang Y, Cao Q, et al: Development
and function of Foxp3(+) regulatory T cells. Nephrology (Carlton).
21:81–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Paust S and Cantor H: Regulatory T cells
and autoimmune disease. Immunol Rev. 204:195–207. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kryczek I, Liu R, Wang G, Wu K, Shu X,
Szeliga W, Vatan L, Finlayson E, Huang E, Simeone D, et al: FOXP3
defines regulatory T cells in human tumor and autoimmune disease.
Cancer Res. 69:3995–4000. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yamamoto T, Yanagimoto H, Satoi S,
Toyokawa H, Hirooka S, Yamaki S, Yui R, Yamao J, Kim S and Kwon AH:
Circulating CD4+CD25+ regulatory T cells in patients with
pancreatic cancer. Pancreas. 41:409–415. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Watanabe MA, Oda JM, Amarante MK and Cesar
Voltarelli J: Regulatory T cells and breast cancer: Implications
for immunopathogenesis. Cancer Metastasis Rev. 29:569–579. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yan F, Du R, Wei F, Zhao H, Yu J, Wang C,
Zhan Z, Ding T, Ren X, Chen X and Li H: Expression of TNFR2 by
regulatory T cells in peripheral blood is correlated with clinical
pathology of lung cancer patients. Cancer Immunol Immunother.
64:1475–1485. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sakaguchi S, Sakaguchi N, Shimizu J,
Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M and
Takahashi T: Immunologic tolerance maintained by CD25+ CD4+
regulatory T cells: Their common role in controlling autoimmunity,
tumor immunity, and transplantation tolerance. Immunol Rev.
182:18–32. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Maynard CL, Hatton RD, Helms WS, Oliver
JR, Stephensen CB and Weaver CT: Contrasting roles for all-trans
retinoic acid in TGF-beta-mediated induction of Foxp3 and Il10
genes in developing regulatory T cells. J Exp Med. 206:343–357.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dennis KL, Blatner NR, Gounari F and
Khazaie K: Current status of interleukin-10 and regulatory T-cells
in cancer. Curr Opin Oncol. 25:637–645. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tucci M, Stucci S, Passarelli A, Giudice
G, Dammacco F and Silvestris F: The immune escape in melanoma: Role
of the impaired dendritic cell function. Expert Rev Clin Immunol.
10:1395–1404. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Raker VK, Domogalla MP and Steinbrink K:
Tolerogenic dendritic cells for regulatory T cell induction in man.
Front Immunol. 6:5692015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cai T, Mazzoli S, Meacci F, Tinacci G,
Nesi G, Zini E and Bartoletti R: Interleukin-6/10 ratio as a
prognostic marker of recurrence in patients with intermediate risk
urothelial bladder carcinoma. J Urol. 178:1906–1912. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gupta M, Han JJ, Stenson M, Maurer M,
Wellik L, Hu G, Ziesmer S, Dogan A and Witzig TE: Elevated serum
IL-10 levels in diffuse large B-cell lymphoma: A mechanism of
aberrant JAK2 activation. Blood. 119:2844–2853. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang BY, Zhan YP, Zong WJ, Yu CJ, Li JF,
Qu YM and Han S: The PD-1/B7-H1 pathway modulates the natural
killer cells versus mouse glioma stem cells. PLoS One.
10:e01347152015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dong H, Strome SE, Salomao DR, Tamura H,
Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, et al:
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential
mechanism of immune evasion. Nat Med. 8:793–800. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kubo S, Yamada T, Osawa Y, Ito Y, Narita N
and Fujieda S: Cytosine-phosphate-guanosine-DNA induces CD274
expression in human B cells and suppresses T helper type 2 cytokine
production in pollen antigen-stimulated CD4-positive cells. Clin
Exp Immunol. 169:1–9. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hudcova K, Raudenska M, Gumulec J, Binkova
H, Horakova Z, Kostrica R, Babula P, Adam V and Masarik M:
Expression profiles of miR-29c, miR-200b and miR-375 in tumour and
tumour-adjacent tissues of head and neck cancers. Tumour Biol.
37:12627–12633. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ye SB, Li ZL, Luo DH, Huang BJ, Chen YS,
Zhang XS, Cui J, Zeng YX and Li J: Tumor-derived exosomes promote
tumor progression and T-cell dysfunction through the regulation of
enriched exosomal microRNAs in human nasopharyngeal carcinoma.
Oncotarget. 5:5439–5452. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li L, Jia J, Liu X, Yang S, Ye S, Yang W
and Zhang Y: MicroRNA-16-5p controls development of osteoarthritis
by targeting SMAD3 in chondrocytes. Curr Pharm Des. 21:5160–5167.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang R, Chen X, Xu T, Xia R, Han L, Chen
W, De W and Shu Y: MiR-326 regulates cell proliferation and
migration in lung cancer by targeting phox2a and is regulated by
HOTAIR. Am J Cancer Res. 6:173–186. 2016.PubMed/NCBI
|
|
38
|
Zhi F, Zhou G, Shao N, Xia X, Shi Y, Wang
Q, Zhang Y, Wang R, Xue L, Wang S, et al: miR-106a-5p inhibits the
proliferation and migration of astrocytoma cells and promotes
apoptosis by targeting FASTK. PLoS One. 8:e723902013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Huang YS, Chang CC, Lee SS, Jou YS and
Shih HM: Xist reduction in breast cancer upregulates AKT
phosphorylation via HDAC3-mediated repression of PHLPP1 expression.
Oncotarget. 7:43256–43266. 2016.PubMed/NCBI
|
|
40
|
Li X, Lin Y, Yang X, Wu X and He X: Long
noncoding RNA H19 regulates EZH2 expression by interacting with
miR-630 and promotes cell invasion in nasopharyngeal carcinoma.
Biochem Biophys Res Commun. 473:913–919. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Huang NS, Chi YY, Xue JY, Liu MY, Huang S,
Mo M, Zhou SL and Wu J: Long non-coding RNA metastasis associated
in lung adenocarcinoma transcript 1 (MALAT1) interacts with
estrogen receptor and predicted poor survival in breast cancer.
Oncotarget. 7:37957–37965. 2016.PubMed/NCBI
|
|
42
|
Jiao F, Hu H, Yuan C and Wang L, Jiang W,
Jin Z, Guo Z and Wang L: Elevated expression level of long
noncoding RNA MALAT-1 facilitates cell growth, migration and
invasion in pancreatic cancer. Oncol Rep. 32:2485–2492. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen H, Xin Y, Zhou L, Huang JM, Tao L,
Cheng L and Tian J: Cisplatin and paclitaxel target significant
long noncoding RNAs in laryngeal squamous cell carcinoma. Med
Oncol. 31:2462014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xie H, Ren X, Xin S, Lan X, Lu G, Lin Y,
Yang S, Zeng Z, Liao W, Ding YQ and Liang L: Emerging roles of
circRNA_001569 targeting miR-145 in the proliferation and invasion
of colorectal cancer. Oncotarget. 7:26680–26691. 2016.PubMed/NCBI
|
